Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
PREVU* POC Skin Sterol Test available for sale in Canada, U.S. markets
March 3rd, 2005
Predictive medicine company IMI International Medical Innovations Inc. (TSX:IMI; Amex: IME) announced that PREVU* Point of Care Skin Sterol Test, a noninvasive, predictive test for coronary artery disease, is now available for sale in Canada and the United States. PREVU*, which measures the amount of cholesterol, or sterol, accumulated in the skin tissues, is marketed and distributed worldwide by McNeil Consumer Healthcare. "IMI is excited about the potential for PREVU* in North America and other major world markets," said Dr. Brent Norton, president and chief executive officer of IMI. "Over the past several months, we have worked closely with McNeil...
Source: Women's Health Weekly (2005-03-03)
|
